Minerva Surgical
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Minerva Surgical generated cash of -$35,567,000, which is less than the previous year. Cash used in financing activities reached the amount of -$4,964,000 last year. Net change in cash is therefore -$40,604,000.

Cash Flow

Minerva Surgical, Inc. (NASDAQ:UTRS): Cash Flow
2019 -19.79M -223K 43.15M
2020 -12.24M -15.45M 18.07M
2021 -22.37M -25.58M 71.21M
2022 -35.56M -73K -4.96M

UTRS Cash Flow Statement (2019 โ€“ 2022)

2022 2021 2020 2019
Cash at beginning of period
48.41M25.16M34.78M11.64M
Operating activities
Net income
-34.11M-21.46M-18.26M-52.04M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
10.80M10.62M7.07M1.67M
Stock-based compensation expense
6.97M6.81M858K587K
Deferred income tax benefit 6.97M6.81M858K587K
Changes in operating assets and liabilities:
Accounts receivable, net
48K1.08M-4.43M-332K
Inventories
-4.13M-9.07M1.26M835K
Accounts payable
-881K3.3M-687K-2.98M
Cash generated by operating activities
-35.56M-22.37M-12.24M-19.79M
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-73K-584K-453K-223K
Acquisitions Net
00-15M0
Cash generated by investing activities
-73K-25.58M-15.45M-223K
Financing activities
Common Stock Issued
36K70.72M118K110K
Payments for dividends
0000
Repurchases of common stock
0000
Repayments of term debt
0-35.37M-17.95M43.80M
Cash used in financing activities
-4.96M71.21M18.07M43.15M
Net Change In Cash
-40.60M23.24M-9.61M23.14M
Cash at end of period
7.81M48.41M25.16M34.78M
Data sourceData source